NODAT, which was significantly more common with ciclosporin in the main analysis, failed to reach significance when including only the studies with lower risk of bias, with the 95% CI expanding from 0.47–0.77 in the main anlaysis to 0.38–1.02 in the low bias sensitivity analysis (around pooled risk ratios of 0.60 and 0.62, respectively).
← all excerpts
Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant.
1
—
—